Tanespimycin pharmacokinetics: Results of a randomized dose-escalation crossover phase 1 study of two formulations

Authors
Category Primary study
JournalMOLECULAR CANCER THERAPEUTICS
Year 2009
This article has no abstract
Epistemonikos ID: 4c3853b396489410739a2d5b72165b12bdd258cc
First added on: Mar 01, 2025